Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 293 followers
Latest posts
Last updated about 12 hours ago
Letter of intent for the submission of a worksharing procedure to the European Medicines Agency according to Article 65 of Regulation (EU) 2019/6
about 13 hours ago
Letter of intent for the submission of a worksharing procedure to the...
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 13, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation: 11/02/2021, Revision: 8, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Ogluo, glucagon, Date of authorisation...
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date of authorisation: 07/01/2021, Revision: 10, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Roclanda, latanoprost / netarsudil, Date...
Human medicines European public assessment report (EPAR): Abecma, idecabtagene vicleucel, Date of authorisation: 18/08/2021, Revision: 13, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Abecma, idecabtagene vicleucel, Date of...
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation: 18/07/2025, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Conexxence, denosumab, Date of authorisation...
Quick guide to competing interests for EMA experts
about 14 hours ago
Quick guide to competing interests for EMA experts
Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders
about 14 hours ago
Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU)...
Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 19, Status: Authorised
about 14 hours ago
Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation...
Workshop on a tailored clinical approach in biosimilar development, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 September 2025, 09:00 (CEST) to 22 September 2025, 16:00 (CEST)
about 15 hours ago
Workshop on a tailored clinical approach in biosimilar development, Online, European Medicines...